The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
Abstract
Disulfide bonds have been widely used to develop reduction-responsive drug-delivery systems (DDS) for cancer therapy. We propose that disulfide bonds might be also used as an oxidation-responsive linkage just like thioether bonds, which can be oxidized to hydrophilic sulfoxide or sulphone in the presence of oxidation stimuli. To test our hypothesis, we design three novel paclitaxel-citronellol conjugates linked via different lengths of disulfide-bond-containing carbon chain. The prodrugs can self-assemble into uniform-size nanoparticles with impressively high drug loading (>55%). As expected, the disulfide-bond-bridged prodrug nanoparticles show redox dual-responsive drug release. More interestingly, the position of disulfide bonds in the carbon chain linkage has profound impacts on the redox dual responsiveness, thereby affecting the drug release, cytotoxicity, pharmacokinetics, biodistribution, and in vivo antitumor efficacy of prodrug nanoassemblies. The redox dual-responsive mechanism is elucidated, and how the position of disulfide bonds in the carbon chain affects the redox dual responsiveness and antitumor efficiency of prodrug nanoassemblies is also clarified. Our findings give new insight into the stimuli responsiveness of disulfide bonds and provide a good foundation for the development of novel redox dual-responsive DDS for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Photonic Synapses Based on Inorganic Perovskite Quantum Dots for Neuromorphic Computing
Wang, Y., Lv, Z., Chen, J., Wang, Z., Zhou, Y., Zhou, L., Chen, X., & Han, S. (2018) · Advanced Materials · doi:10.1002/adma.201802883 · Cited by 700
Self-citationLuo, C., Sun, J., Liu, D., Sun, B., Miao, L., Musetti, S., Li, J., Han, X., Du, Y., Li, L., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01632 · Cited by 443
Self-citationTumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy
Wang, J., Sun, X., Mao, W., Sun, W., Tang, J., Sui, M., Shen, Y., & Gu, Z. (2013) · Advanced Materials · doi:10.1002/adma.201300929 · Cited by 395
Overchuk, M., & Zheng, G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.024 · Cited by 383
PEGylation in anti-cancer therapy: An overview
Mishra, P., Nayak, B., & Dey, R. K. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.08.011 · Cited by 382
Cheetham, A. G., Chakroun, R. W., Ma, W., & Cui, H. (2017) · Chem. Soc. Rev. · doi:10.1039/c7cs00521k · Cited by 367
Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy
Li, X., Kim, J., Yoon, J., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201606857 · Cited by 362
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy
Luo, C., Sun, J., Sun, B., & He, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.008 · Cited by 352
Self-citationGemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
Maiti, S., Park, N., Han, J. H., Jeon, H. M., Lee, J. H., Bhuniya, S., Kang, C., & Kim, J. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401350x · Cited by 327
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Walther, R., Rautio, J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.013 · Cited by 288
Wang, Y., Liu, D., Zheng, Q., Zhao, Q., Zhang, H., Ma, Y., Fallon, J. K., Fu, Q., Haynes, M. T., Lin, G., et al. (2014) · Nano Letters · doi:10.1021/nl502044x · Cited by 252
Self-citationRemodeling the Tumor Microenvironment with Emerging Nanotherapeutics
Chen, Q., Liu, G., Liu, S., Su, H., Wang, Y., Li, J., & Luo, C. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.009 · Cited by 229
Self-citationPaclitaxel: biosynthesis, production and future prospects
Howat, S., Park, B., Oh, I. S., Jin, Y.-W., Lee, E.-K., & Loake, G. J. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.02.010 · Cited by 208
Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
Bocci, G., & Kerbel, R. S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.64 · Cited by 207
Zhang, F., Zhu, G., Jacobson, O., Liu, Y., Chen, K., Yu, G., Ni, Q., Fan, J., Yang, Z., Xu, F., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b03003 · Cited by 182
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
Samanta, S. K., Quigley, J., Vinciguerra, B., Briken, V., & Isaacs, L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05154 · Cited by 176
Luo, C., Sun, J., Sun, B., Liu, D., Miao, L., Goodwin, T. J., Huang, L., & He, Z. (2016) · Small · doi:10.1002/smll.201601597 · Cited by 174
Self-citationChemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy
Sun, B., Luo, C., Cui, W., Sun, J., & He, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.034 · Cited by 160
Self-citationResponsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
Liu, Y., Xu, C., Iqbal, S., Yang, X., & Wang, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.004 · Cited by 131
Xiao, C., Ding, J., Ma, L., Yang, C., Zhuang, X., & Chen, X. (2014) · Polymer Chemistry · doi:10.1039/c4py01156b · Cited by 115
Stimuli-responsive nanocarriers for intracellular delivery
Tayo, L. L. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0341-z · Cited by 94
Dosio, F., Reddy, L. H., Ferrero, A., Stella, B., Cattel, L., & Couvreur, P. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100154g · Cited by 90
Novel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery
Mura, S., Zouhiri, F., Lerondel, S., Maksimenko, A., Mougin, J., Gueutin, C., Brambilla, D., Caron, J., Śliwiński, É., Pape, A. L., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400210x · Cited by 51
Cited by
Stimuli‐Responsive Nanocomposite Hydrogels for Biomedical Applications
Lavrador, P., Esteves, M. R., Gaspar, V. M., & Mano, J. F. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202005941 · Cited by 536
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Self-citationPark, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 382
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
Sun, B., Luo, C., Zhang, X., Guo, M., Sun, M., Yu, H., Chen, Q., Yang, W., Wang, M., Zuo, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11193-x · Cited by 319
Self-citationYang, Y., Sun, B., Zuo, S., Li, X., Zhou, S., Li, L., Luo, C., Liu, H., Cheng, M., Wang, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1725 · Cited by 307
Self-citation
Metadata
- Authors
- Sun, B., Luo, C., Yu, H., Zhang, X., Chen, Q., Yang, W., Wang, M., Kan, Q., Zhang, H., Wang, Y., He, Z., & Sun, J.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-05-04
- Volume
- 18
- Issue
- 6
- Pages
- 3643-3650
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2799378760
- Cited by
- 426
- References
- 25
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.